G T Ferguson
Overview
Explore the profile of G T Ferguson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
769
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jenkins C, Celli B, ANDERSON J, Ferguson G, Jones P, Vestbo J, et al.
Eur Respir J
. 2011 Jul;
39(1):38-45.
PMID: 21737561
We investigated the impact of season relative to other determinants of chronic obstructive pulmonary disease (COPD) exacerbation frequency in a long-term international study of patients with forced expiratory volume in...
2.
Keene O, Vestbo J, ANDERSON J, Calverley P, Celli B, Ferguson G, et al.
Eur Respir J
. 2009 Nov;
34(5):1018-23.
PMID: 19880616
The TORCH (Towards a Revolution in COPD Health) trial has highlighted some important issues in the design and analysis of long term trials in chronic obstructive pulmonary disease. These include...
3.
Vestbo J, ANDERSON J, Calverley P, Celli B, Ferguson G, Jenkins C, et al.
Thorax
. 2009 Aug;
64(11):939-43.
PMID: 19703830
Background: Little is known about adherence to inhaled medication in chronic obstructive pulmonary disease (COPD) and the impact on mortality and morbidity. Methods: Data on drug adherence from a randomised...
4.
Crim C, Calverley P, ANDERSON J, Celli B, Ferguson G, Jenkins C, et al.
Eur Respir J
. 2009 May;
34(3):641-7.
PMID: 19443528
Inhaled corticosteroids (ICS) are important in reducing exacerbation frequency associated with chronic obstructive pulmonary disease (COPD). However, little is known about the risk of associated infections. In a post hoc...
5.
Keene O, Celli B, ANDERSON J, Ferguson G, Jenkins C, Jones P, et al.
Eur Respir J
. 2009 Mar;
33(3):708-9.
PMID: 19251815
No abstract available.
6.
Ferguson G
Clin Chest Med
. 2001 Feb;
21(4):723-38.
PMID: 11194782
As described throughout this article, significant improvements continue to occur in the pharmacologic management of COPD. These improvements range from improved medication targeting to better understanding of mechanisms of action,...
7.
Ferguson G, Enright P, Buist A, Higgins M
Respir Care
. 2000 May;
45(5):513-30.
PMID: 10813228
Chronic obstructive pulmonary disease (COPD) is easily detected in its preclinical phase using spirometry, and successful smoking cessation (a cost-effective intervention) prevents further disease progression. This consensus statement recommends the...
8.
Ferguson G, Enright P, Buist A, Higgins M
Chest
. 2000 Apr;
117(4):1146-61.
PMID: 10767253
COPD is easily detected in its preclinical phase using spirometry, and successful smoking cessation (a cost-effective intervention) prevents further disease progression. This consensus statement recommends the widespread use of office...
9.
Ferguson G
Chest
. 2000 Feb;
117(2 Suppl):23S-8S.
PMID: 10673470
Three sets of guidelines for the management of COPD that are widely recognized (from the European Respiratory Society [ERS], American Thoracic Society [ATS], and British Thoracic Society [BTS]) are reviewed...
10.
Dorinsky P, Reisner C, Ferguson G, Menjoge S, Serby C, Witek Jr T
Chest
. 1999 Apr;
115(4):966-71.
PMID: 10208193
Study Objectives: To determine whether the combination of ipratropium bromide and albuterol results in greater and more consistent pulmonary function test (PFT) response rates than ipratropium bromide or albuterol alone...